Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Molecular Diagnostics Market Size study, by Product & Services (Reagents & Kits, Instruments, Services & Software), by Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Others), by Application (Infectious Diseases, Oncology, Genetic Tests, Others), by End-User (Hospital & Academic Laboratories, Reference Laboratories, Others) and Regional Forecasts 2020-2026

  • BIZ3837212
  • 200 Pages
  • April 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Molecular Diagnostics Market is valued approximately at USD 8.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2020-2026. The molecular diagnostics is a technique used to examine biological markers involved in a broad range of human ailments. Molecular diagnostic tests are the basic part of a successful healthcare system. Molecular diagnostic tests deliver vital information that helps healthcare patients and providers to make accurate medical decisions for better outcome of a medical procedure. This technique often provides quantitative measurements that inform each stage of care and facilitate successful management of health circumstances. Molecular diagnostics tools enhance the clinical setting, offer sensitive and rapid approaches for the identification and monitor various infectious diseases such as types of cancer, and other chronic diseases. Thus, rise in the incidences of infectious diseases and cancer owing to growing elderly population, along with the growing awareness and acceptance of personalized medicine and companion diagnostics are the few factors responsible for high CAGR of the market over the forecast period. According to the International Agency for Research on Cancer (IARC), in 2018, there were around 17.0 million new cancer cases and 9.5 million cancer deaths registered throughout the world. Also, the global burden of cancer is expected to grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This, in turn, is expected to accelerate the demand for Molecular Diagnostics, thus contributing to the growth of the global market. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Molecular Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of cancer and infectious diseases, presence of a well-developed healthcare infrastructure and rapid rise in clinical laboratories across the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to increased healthcare spending by a larger population base and growing aging population in the countries like China and India.

Major market player included in this report are:

Abbott Laboratories

Becton, Dickinson and Company

Agilent Technologies, Inc.

Biomérieux Sa

Danaher Corporation

DiaSorin

Grifols, S.A.

Hologic, Inc.

Illumina, Inc.

Thermo Fisher Scientific, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Services:

Reagents & Kits

Instruments

Services & Software

By Technology:

Polymerase Chain Reaction (PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

DNA Sequencing & Next-Generation Sequencing (NGS)

DNA Microarray

Others

By Application:

Infectious Diseases

Oncology

Genetic Tests

Others

By End-User:

Hospital & Academic Laboratories

Reference Laboratories

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 2019

Forecast period – 2020 to 2026

Target Audience of the Global Molecular Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)

1.2.1. Molecular Diagnostics Market, by Region, 2018-2026 (USD Billion)

1.2.2. Molecular Diagnostics Market, by Product & Services, 2018-2026 (USD Billion)

1.2.3. Molecular Diagnostics Market, by Technology, 2018-2026 (USD Billion)

1.2.4. Molecular Diagnostics Market, by Application, 2018-2026 (USD Billion)

1.2.5. Molecular Diagnostics Market, by End-User, 2018-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Molecular Diagnostics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Molecular Diagnostics Market Dynamics

3.1. Molecular Diagnostics Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Molecular Diagnostics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Molecular Diagnostics Market, by Product & Services

5.1. Market Snapshot

5.2. Global Molecular Diagnostics Market by Product & Services, Performance - Potential Analysis

5.3. Global Molecular Diagnostics Market Estimates & Forecasts by Product & Services 2016-2026 (USD Billion)

5.4. Molecular Diagnostics Market, Sub Segment Analysis

5.4.1. Reagents & Kits

5.4.2. Instruments

5.4.3. Services & Software

Chapter 6. Global Molecular Diagnostics Market, by Technology

6.1. Market Snapshot

6.2. Global Molecular Diagnostics Market by Technology, Performance - Potential Analysis

6.3. Global Molecular Diagnostics Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)

6.4. Molecular Diagnostics Market, Sub Segment Analysis

6.4.1. Polymerase Chain Reaction (PCR)

6.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)

6.4.3. DNA Sequencing & Next-Generation Sequencing (NGS)

6.4.4. DNA Microarray

6.4.5. Others

Chapter 7. Global Molecular Diagnostics Market, by Application

7.1. Market Snapshot

7.2. Global Molecular Diagnostics Market by Application, Performance - Potential Analysis

7.3. Global Molecular Diagnostics Market Estimates & Forecasts by Application 2016-2026 (USD Billion)

7.4. Molecular Diagnostics Market, Sub Segment Analysis

7.4.1. Infectious Diseases

7.4.2. Oncology

7.4.3. Genetic Tests

7.4.4. Others

Chapter 8. Global Molecular Diagnostics Market, by End-User

8.1. Market Snapshot

8.2. Global Molecular Diagnostics Market by End-User, Performance - Potential Analysis

8.3. Global Molecular Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)

8.4. Molecular Diagnostics Market, Sub Segment Analysis

8.4.1. Hospital & Academic Laboratories

8.4.2. Reference Laboratories

8.4.3. Others

Chapter 9. Global Molecular Diagnostics Market, Regional Analysis

9.1. Molecular Diagnostics Market, Regional Market Snapshot

9.2. North America Molecular Diagnostics Market

9.2.1. U.S. Molecular Diagnostics Market

9.2.1.1. Product & Services breakdown estimates & forecasts, 2016-2026

9.2.1.2. Technology breakdown estimates & forecasts, 2016-2026

9.2.1.3. Application breakdown estimates & forecasts, 2016-2026

9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026

9.2.2. Canada Molecular Diagnostics Market

9.3. Europe Molecular Diagnostics Market Snapshot

9.3.1. U.K. Molecular Diagnostics Market

9.3.2. Germany Molecular Diagnostics Market

9.3.3. Rest of Europe Molecular Diagnostics Market

9.4. Asia-Pacific Molecular Diagnostics Market Snapshot

9.4.1. China Molecular Diagnostics Market

9.4.2. India Molecular Diagnostics Market

9.4.3. Japan Molecular Diagnostics Market

9.4.4. Rest of Asia Pacific Molecular Diagnostics Market

9.5. Latin America Molecular Diagnostics Market Snapshot

9.5.1. Brazil Molecular Diagnostics Market

9.5.2. Mexico Molecular Diagnostics Market

9.6. Rest of The World Molecular Diagnostics Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Abbott Laboratories

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Becton, Dickinson and Company

10.2.3. Agilent Technologies, Inc.

10.2.4. Biomérieux Sa

10.2.5. Danaher Corporation

10.2.6. DiaSorin

10.2.7. Grifols, S.A.

10.2.8. Hologic, Inc.

10.2.9. Illumina, Inc.

10.2.10. Thermo Fisher Scientific, Inc.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET

TABLE 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICES 2016-2026 (USD BILLION)

TABLE 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)

TABLE 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)

TABLE 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)

TABLE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 21. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 22. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 23. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 24. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 25. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 26. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 27. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 28. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 29. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 30. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 31. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 32. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 33. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 34. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 35. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 36. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 37. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 38. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 39. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 40. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 41. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 42. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 43. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 44. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 45. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 46. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 47. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 48. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 49. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 50. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 51. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 52. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 53. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 54. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 55. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 56. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 57. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 58. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 59. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research